Moreover, Cheng et al. (36) found that IL-22, a cytokine involved in immune response and inflammation, might be a potential mediator of associations between urinary PAH metabolites and health outcomes including fasting plasma glucose and type 2 diabetes. This evidence concerns the gene IL22 and type 2 diabetes mellitus.